Prognostic factors and long‐term follow‐up of basiliximab for steroid‐refractory acute graft‐versus‐host disease : Updated experience from a large‐scale study-Reference-Cited by-同舟云学术

Prognostic factors and long‐term follow‐up of basiliximab for steroid‐refractory acute graft‐versus‐host disease : Updated experience from a large‐scale study

Published:2020-05-07 Issue:8 Volume:95 Page:927-936
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Liu Si‐Ning¹^ORCID,Zhang Xiao‐Hui¹^ORCID,Xu Lan‐Ping¹²,Wang Yu¹^ORCID,Yan Chen‐Hua¹,Chen Huan¹,Chen Yu‐Hong¹^ORCID,Han Wei¹,Wang Feng‐Rong¹,Wang Jing‐Zhi¹,Liu Kai‐Yan¹,Huang Xiao‐Jun¹³²^ORCID,Mo Xiao‐Dong¹²^ORCID

Affiliation:

1. Peking University People's Hospital, Peking University Institute of HematologyNational Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation Beijing China

2. Research Unit of Key Technique for Diagnosis and Treatments of Hematologic MalignanciesChinese Academy of Medical Sciences, 2019RU029 Beijing China

3. Peking‐Tsinghua Center for Life Sciences Beijing 100044 China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25839

Reference56 articles.

1. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology

2. Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

3. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

4. Treatment and management of graft-versus-host disease: improving response and survival

5. First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruxolitinib Plus Basiliximab Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease in Unrelated Cord Blood Transplantation: A Large-Scale Study;Transplantation and Cellular Therapy;2024-09

2. Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease;Frontiers in Immunology;2024-07-03

3. Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial;BMC Medicine;2024-04-25

4. Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment;Frontiers in Oncology;2024-03-26

5. Ruxolitinib plus basiliximab therapy for steroid-refractory acute graft-versus-host disease in unrelated cord blood transplantation: a large-scale study;2024-03-21